|
KMID : 1011320080010010013
|
|
Journal of Pharmacoepidemiology and Risk Management
2008 Volume.1 No. 1 p.13 ~ p.19
|
|
|
Drug Utilization Review
|
|
Park Byung-Joo
|
|
|
Abstract
|
|
|
|
Drug utilization was defined by World Health Organization as the “marketing, distribution, prescription, and use of drugs in a society, with special emphasis on the resulting medical, social, and economic consequences.” And drug utilization review programs have been defined as “structured, ongoing initiatives that interpret patterns of drug use in relation to predetermined criteria, and attempt to prevent or minimize inappropriate prescribing.” This paper introduces the concept and purpose of drug utilization review (DUR). DUR can be classified as retrospective DUR, prospective DUR, and concurrent DUR based on the time direction of applying DUR. DUR can also be classified as quantitative DUR defined by retrospective DUR using databases including previously prescribed medicines, and qualitative DUR defined by DUR reflecting patient’s medical condition. The history of developing DUR in the United States and Europe, databases for applying DUR, and an example of applying DUR is introduced briefly. Finally current status of DUR in Korea is described briefly and the direction of future development of DUR in Korea is also suggested.
|
|
|
KEYWORD
|
|
|
Drug utilization review (DUR), Quantitative DUR, Qualitative DUR, DUR programs, Database, Pharmacoepidemiology
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|